Advanced search
Publication Cover
OncoImmunology Volume 1, 2012 - Issue 5
Submit an article Journal homepage
865
Views
33
CrossRef citations to date
0
Altmetric
Author's View

Tumor high endothelial venules (HEVs) predict lymphocyte infiltration and favorable prognosis in breast cancer

Ludovic Martinet CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale); Toulouse, France; Université de Toulouse; UPS; IPBS; Toulouse, France
,
Ignacio Garrido CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale); Toulouse, France; Université de Toulouse; UPS; IPBS; Toulouse, France; Institut Claudius Regaud; Toulouse, France
&
Jean-Philippe Girard CNRS; IPBS (Institut de Pharmacologie et de Biologie Structurale); Toulouse, France; Université de Toulouse; UPS; IPBS; Toulouse, FranceCorrespondence[email protected]
Pages 789-790 | Published online: 24 Aug 2012

References

  • Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pagès C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313:1960 - 4; http://dx.doi.org/10.1126/science.1129139; PMID: 17008531
  • Denkert C, Loibl S, Noske A, Roller M, Müller BM, Komor M, et al. Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. J Clin Oncol 2010; 28:105 - 13; http://dx.doi.org/10.1200/JCO.2009.23.7370; PMID: 19917869
  • Girard JP, Springer TA. High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. Immunol Today 1995; 16:449 - 57; http://dx.doi.org/10.1016/0167-5699(95)80023-9; PMID: 7546210
  • Martinet L, Garrido I, Filleron T, Le Guellec S, Bellard E, Fournie JJ, et al. Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer. Cancer Res 2011; 71:5678 - 87; http://dx.doi.org/10.1158/0008-5472.CAN-11-0431; PMID: 21846823
  • Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol 2006; 6:715 - 27; http://dx.doi.org/10.1038/nri1936; PMID: 16977338
  • Buckanovich RJ, Facciabene A, Kim S, Benencia F, Sasaroli D, Balint K, et al. Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. Nat Med 2008; 14:28 - 36; http://dx.doi.org/10.1038/nm1699; PMID: 18157142
  • von Andrian UH, Mempel TR. Homing and cellular traffic in lymph nodes. Nat Rev Immunol 2003; 3:867 - 78; http://dx.doi.org/10.1038/nri1222; PMID: 14668803
  • Schrama D, thor Straten P, Fischer WH, McLellan AD, Bröcker EB, Reisfeld RA, et al. Targeting of lymphotoxin-alpha to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue. Immunity 2001; 14:111 - 21; http://dx.doi.org/10.1016/S1074-7613(01)00094-2; PMID: 11239444
  • Moussion C, Girard JP. Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules. Nature 2011; 479:542 - 6; http://dx.doi.org/10.1038/nature10540; PMID: 22080953

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.